Palladiem »

Halozyme Therapeutics shares owned by Palladiem

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Palladiem from 13F filings

Historical chart of Palladiem investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Palladiem consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Palladiem

Quarter filed Position value Share count Share price at filing
2025-12-31 $118k 1.7k 67.70

More positions owned by Palladiem

Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Equal Weighted Etf Etf (EUSA)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Spdr Msci Eafe Strategicfactors Etf Etf (QEFA)
Spdr Gold Minishares Etv Etf (GLDM)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
St Stert Spdr Blmbg 1 3 Mn T Bl Etf Etf (BIL)
Idx Dynamic Fixed Income Etf Etf (DYFI)
Ishares Msci Intl Quality Factor Etf Etf (IQLT)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Idx Alternative Fiat Etf Etf (GLDB)
Vanguard Short-term Inflation-protected Securities Etf Etf (VTIP)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Matthews Emerging Markets Equity Active Etf Etf (MEM)
Ishares Global Materials Etf Etf (MXI)

View all positions for Palladiem

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics